Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.
Source: [Inc.](https://www.inc.com/lucia-auerbach/alzheimers-drug-cut-expected-cognitive-decline-roughly-in-half/91385223)